Use of faricimab for refractory diabetic macular edema in real-world clinical practice: When anatomical success meets functional limits. [PDF]
Gu Z, Xi T, Luo X.
europepmc +1 more source
Faricimab Improves Choriocapillaris Perfusion in Diabetic Macular Edema. [PDF]
Lee SY, Kim J, Han YE, Lee J.
europepmc +1 more source
Faricimab versus Aflibercept for Discharge and Readmission in Neovascular Age-Related Macular Degeneration: A Lesion-Type Stratified, Real-World UK Analysis. [PDF]
Singh Bhangu J +7 more
europepmc +1 more source
Two-year real-world effectiveness of faricimab after treatment switch in neovascular age-related macular degeneration. [PDF]
Ruiz-Medrano J +3 more
europepmc +1 more source
Early Effect of Intravitreal Faricimab on Hard Exudates in Diabetic Macular Oedema. [PDF]
Kumar A +4 more
europepmc +1 more source
Short-term morphological and functional outcomes of intravitreal faricimab for chorioretinal disorders: a real-world study in a Chinese population. [PDF]
Jin E +5 more
europepmc +1 more source
Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study. [PDF]
Mira F +14 more
europepmc +1 more source
Treatment-Emergent Epiretinal Membrane in Diabetic Macular Edema: A Real-World OCT-Based Comparative Pharmacotherapy Study Across Intravitreal Agents-The TRIDENT-DME Study. [PDF]
Chakraborty D +7 more
europepmc +1 more source
Modulation of aqueous humor cytokine profile by faricimab in patients with diabetic macular edema. [PDF]
Wan Z +5 more
europepmc +1 more source

